{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T00:45:24Z","timestamp":1767141924557,"version":"build-2238731810"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T00:00:00Z","timestamp":1748563200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T00:00:00Z","timestamp":1748563200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Health Research Project of Hunan Provincial Health Commission","award":["20231973"],"award-info":[{"award-number":["20231973"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s11033-025-10600-5","type":"journal-article","created":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T09:27:28Z","timestamp":1748597248000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Upregulation of miR-155-5p impaired ginsenoside Rg1-mediated wound healing in diabetic foot ulcers by targeting E2F2\/CDCA7L signaling"],"prefix":"10.1007","volume":"52","author":[{"given":"Meimei","family":"Xiao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cancai","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chenhao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,5,30]]},"reference":[{"key":"10600_CR1","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1001\/jama.2023.10578","volume":"330","author":"DG Armstrong","year":"2023","unstructured":"Armstrong DG, Tan T-W, Boulton AJM, Bus SA (2023) Diabetic foot ulcers: A review. JAMA 330:62\u201375. https:\/\/doi.org\/10.1001\/jama.2023.10578","journal-title":"JAMA"},{"key":"10600_CR2","doi-asserted-by":"publisher","first-page":"209","DOI":"10.2337\/dci22-0043","volume":"46","author":"K McDermott","year":"2022","unstructured":"McDermott K, Fang M, Boulton AJM, Selvin E, Hicks CW (2022) Etiology, epidemiology, and disparities in the burden of diabetic foot ulcers. Diabetes Care 46:209\u2013221. https:\/\/doi.org\/10.2337\/dci22-0043. Diabetes Care","journal-title":"Diabetes Care"},{"key":"10600_CR3","doi-asserted-by":"publisher","unstructured":"Tang WH, Zhao YN, Cheng ZX, Xu JX, Zhang Y, Liu XM (2023) Risk factors for diabetic foot ulcers: A systematic review and meta-analysis. Vascular 17085381231154805. https:\/\/doi.org\/10.1177\/17085381231154805","DOI":"10.1177\/17085381231154805"},{"key":"10600_CR4","doi-asserted-by":"publisher","first-page":"101909","DOI":"10.1016\/j.foot.2022.101909","volume":"52","author":"A Jodheea-Jutton","year":"2022","unstructured":"Jodheea-Jutton A, Hindocha S, Bhaw-Luximon A (2022) Health economics of diabetic foot ulcer and recent trends to accelerate treatment. Foot 52:101909. https:\/\/doi.org\/10.1016\/j.foot.2022.101909","journal-title":"Foot"},{"key":"10600_CR5","doi-asserted-by":"publisher","unstructured":"Ramachandran V, Mohanasundaram T, Karunakaran D, Gunasekaran M, Tiwari R (2023) Physiological and pathophysiological aspects of diabetic foot ulcer and its treatment strategies. Curr Diabetes Rev 19(e031122210617). https:\/\/doi.org\/10.2174\/1573399819666221103141715","DOI":"10.2174\/1573399819666221103141715"},{"key":"10600_CR6","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1002\/ptr.8018","volume":"38","author":"J Zhen","year":"2024","unstructured":"Zhen J, Bai J, Liu J, Men H, Yu H (2024) Ginsenoside RG1-induced mesenchymal stem cells alleviate diabetic cardiomyopathy through secreting Exosomal circNOTCH1 to promote macrophage M2 polarization. Phytother Res 38:1745\u20131760. https:\/\/doi.org\/10.1002\/ptr.8018","journal-title":"Phytother Res"},{"key":"10600_CR7","doi-asserted-by":"publisher","unstructured":"Ma T, Mao X, Meng X, Wang Q (2022) Ginsenoside Rg1 inhibits STAT3 expression by miR-15b-5p to attenuate lung injury in mice with type 2 diabetes Mellitus-Associated pulmonary tuberculosis. Evid Based Complement Alternat Med 2022(9017021). https:\/\/doi.org\/10.1155\/2022\/9017021","DOI":"10.1155\/2022\/9017021"},{"key":"10600_CR8","doi-asserted-by":"publisher","unstructured":"Han Y, Su Y, Han M, Liu Y, Shi Q, Li X, Wang P, Li W, Li W (2023) Ginsenoside Rg1 attenuates glomerular fibrosis by inhibiting CD36\/TRPC6\/NFAT2 signaling in type 2 diabetes mellitus mice. Journal of ethnopharmacology 302, 115923. https:\/\/doi.org\/10.1016\/j.jep.2022.115923","DOI":"10.1016\/j.jep.2022.115923"},{"key":"10600_CR9","doi-asserted-by":"publisher","first-page":"1179705","DOI":"10.3389\/fphar.2023.1179705","volume":"14","author":"Q Xie","year":"2023","unstructured":"Xie Q, Zhang X, Zhou Q, Xu Y, Sun L, Wen Q, Wang W, Chen Q (2023) Antioxidant and anti-inflammatory properties of ginsenoside Rg1 for hyperglycemia in type 2 diabetes mellitus: systematic reviews and meta-analyses of animal studies. Front Pharmacol 14:1179705. https:\/\/doi.org\/10.3389\/fphar.2023.1179705","journal-title":"Front Pharmacol"},{"key":"10600_CR10","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.jphs.2021.07.008","volume":"147","author":"L Huang","year":"2021","unstructured":"Huang L, Cai HA, Zhang MS, Liao RY, Huang X, Hu FD (2021) Ginsenoside Rg1 promoted the wound healing in diabetic foot ulcers via miR-489-3p\/Sirt1 axis. J Pharmacol Sci 147:271\u2013283. https:\/\/doi.org\/10.1016\/j.jphs.2021.07.008","journal-title":"J Pharmacol Sci"},{"key":"10600_CR11","doi-asserted-by":"publisher","first-page":"409","DOI":"10.3389\/fcell.2020.00409","volume":"8","author":"PJ Dexheimer","year":"2020","unstructured":"Dexheimer PJ, Cochella L (2020) MicroRNAs: from mechanism to organism. Front Cell Dev Biol 8:409. https:\/\/doi.org\/10.3389\/fcell.2020.00409","journal-title":"Front Cell Dev Biol"},{"key":"10600_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.placenta.2024.01.011","volume":"148","author":"H Zhang","year":"2024","unstructured":"Zhang H, Jiang Y, Zhu S, Wei L, Zhou X, Gao P, Zhang J, Chen Y, Du Y, Fang C et al (2024) MiR-155-5p improves the insulin sensitivity of trophoblasts by targeting CEBPB in gestational diabetes mellitus. Placenta 148:1\u201311. https:\/\/doi.org\/10.1016\/j.placenta.2024.01.011","journal-title":"Placenta"},{"key":"10600_CR13","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.bbrc.2020.08.073","volume":"532","author":"G Wang","year":"2020","unstructured":"Wang G, Wu B, Zhang B, Wang K, Wang H (2020) LncRNA CTBP1-AS2 alleviates high glucose-induced oxidative stress, ECM accumulation, and inflammation in diabetic nephropathy via miR-155-5p\/FOXO1 axis. Biochem Biophys Res Commun 532:308\u2013314. https:\/\/doi.org\/10.1016\/j.bbrc.2020.08.073","journal-title":"Biochem Biophys Res Commun"},{"key":"10600_CR14","doi-asserted-by":"publisher","unstructured":"Zhang Y, Hei F, Xiao Y, Liu Y, Han J, Hu D, Wang H (2024) Acidic fibroblast growth factor inhibits reactive oxygen species-induced epithelial-mesenchymal transdifferentiation in vascular endothelial cells via the miR-155-5p\/SIRT1\/Nrf2\/HO-1 pathway to promote wound healing in diabetic mice. Burns Trauma 12(tkae010). https:\/\/doi.org\/10.1093\/burnst\/tkae010","DOI":"10.1093\/burnst\/tkae010"},{"key":"10600_CR15","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1055\/a-1989-1918","volume":"131","author":"M Xiao","year":"2023","unstructured":"Xiao M, Wang J, Chen Y (2023) E2F2 promotes wound healing of diabetic foot ulcer by regulating CDCA7L transcription. Experimental and clinical endocrinology & diabetes: official journal. German Soc Endocrinol [and] German Diabetes Association 131:162\u2013172. https:\/\/doi.org\/10.1055\/a-1989-1918","journal-title":"German Soc Endocrinol [and] German Diabetes Association"},{"key":"10600_CR16","unstructured":"Oliver TI, Mutluoglu M (2024) Diabetic Foot Ulcer. In StatPearls, (StatPearls Publishing Copyright \u00a9 2024, StatPearls Publishing LLC.)"},{"key":"10600_CR17","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1139\/cjpp-2023-0193","volume":"101","author":"V Rai","year":"2023","unstructured":"Rai V, Le H, Agrawal DK (2023) Novel mediators regulating angiogenesis in diabetic foot ulcer healing. Can J Physiol Pharmacol 101:488\u2013501. https:\/\/doi.org\/10.1139\/cjpp-2023-0193","journal-title":"Can J Physiol Pharmacol"},{"key":"10600_CR18","doi-asserted-by":"publisher","first-page":"110991","DOI":"10.1016\/j.biopha.2020.110991","volume":"133","author":"Y Wang","year":"2021","unstructured":"Wang Y, Shao T, Wang J, Huang X, Deng X, Cao Y, Zhou M, Zhao C (2021) An update on potential biomarkers for diagnosing diabetic foot ulcer at early stage. Biomed pharmacotherapy = Biomedecine Pharmacotherapie 133:110991. https:\/\/doi.org\/10.1016\/j.biopha.2020.110991","journal-title":"Biomed pharmacotherapy = Biomedecine Pharmacotherapie"},{"key":"10600_CR19","doi-asserted-by":"publisher","first-page":"1010937","DOI":"10.3389\/fphar.2022.1010937","volume":"13","author":"W Chen","year":"2022","unstructured":"Chen W, Jin X, Wang T, Bai R, Shi J, Jiang Y, Tan S, Wu R, Zeng S, Zheng H et al (2022) Ginsenoside Rg1 interferes with the progression of diabetic osteoporosis by promoting type H angiogenesis modulating vasculogenic and osteogenic coupling. Front Pharmacol 13:1010937. https:\/\/doi.org\/10.3389\/fphar.2022.1010937","journal-title":"Front Pharmacol"},{"key":"10600_CR20","doi-asserted-by":"publisher","unstructured":"Liu H, Chen W, Lu P, Ma Y, Liang X, Liu Y (2021) Ginsenoside Rg1 attenuates the inflammation and oxidative stress induced by diabetic nephropathy through regulating the PI3K\/AKT\/FOXO3 pathway. Annals of translational medicine 9, 1789. https:\/\/doi.org\/10.21037\/atm-21-6234","DOI":"10.21037\/atm-21-6234"},{"key":"10600_CR21","doi-asserted-by":"publisher","unstructured":"Peng M, Wang L, Su H, Zhang L, Yang Y, Sun L, Wu Y, Ran L, Liu S, Yin M et al (2022) Ginsenoside Rg1 improved diabetes through regulating the intestinal microbiota in high-fat diet and streptozotocin-induced type 2 diabetes rats. J Food Biochem 46(e14321). https:\/\/doi.org\/10.1111\/jfbc.14321","DOI":"10.1111\/jfbc.14321"},{"key":"10600_CR22","doi-asserted-by":"publisher","first-page":"232","DOI":"10.21037\/atm.2019.12.155","volume":"8","author":"Y Gao","year":"2020","unstructured":"Gao Y, Ji Y, Luo Y, Sun J, Sun G, Sun X (2020) Ginsenoside Rg1 prevents early diabetic retinopathy via reducing retinal ganglion cell layer and inner nuclear layer cell apoptosis in Db\/db mice. Annals Translational Med 8:232. https:\/\/doi.org\/10.21037\/atm.2019.12.155","journal-title":"Annals Translational Med"},{"key":"10600_CR23","doi-asserted-by":"publisher","first-page":"121972","DOI":"10.1016\/j.lfs.2023.121972","volume":"329","author":"M Lu","year":"2023","unstructured":"Lu M, Zhao F, Ran C, Xu Y, Zhang J, Wang H (2023) Ginsenoside Rg1 attenuates diabetic vascular endothelial dysfunction by inhibiting the calpain-1\/ROS\/PKC-\u03b2 axis. Life Sci 329:121972. https:\/\/doi.org\/10.1016\/j.lfs.2023.121972","journal-title":"Life Sci"},{"key":"10600_CR24","doi-asserted-by":"publisher","unstructured":"Mao X, Li Z, Li B, Wang H (2021) Baicalin regulates mRNA expression of VEGF-c, Ang-1\/Tie2, TGF-\u03b2 and Smad2\/3 to inhibit wound healing in streptozotocin-induced diabetic foot ulcer rats. J Biochem Mol Toxicol 35(e22893). https:\/\/doi.org\/10.1002\/jbt.22893","DOI":"10.1002\/jbt.22893"},{"key":"10600_CR25","doi-asserted-by":"publisher","first-page":"5447","DOI":"10.2147\/ijn.S380515","volume":"17","author":"W Shang","year":"2022","unstructured":"Shang W, Zhao X, Yang F, Wang D, Lu L, Xu Z, Zhao Z, Cai H, Shen J (2022) Ginsenoside Rg1 nanoparticles induce demethylation of H3K27me3 in VEGF-A and Jagged 1 promoter regions to activate angiogenesis after ischemic stroke. Int J Nanomed 17:5447\u20135468. https:\/\/doi.org\/10.2147\/ijn.S380515","journal-title":"Int J Nanomed"},{"key":"10600_CR26","doi-asserted-by":"publisher","unstructured":"Deng L, Du C, Song P, Chen T, Rui S, Armstrong DG, Deng W (2021) The Role of Oxidative Stress and Antioxidants in Diabetic Wound Healing. Oxid Med Cell Longev 2021, 8852759. https:\/\/doi.org\/10.1155\/2021\/8852759","DOI":"10.1155\/2021\/8852759"},{"key":"10600_CR27","doi-asserted-by":"publisher","first-page":"1060758","DOI":"10.3389\/fmed.2023.1060758","volume":"10","author":"D Sivaraj","year":"2023","unstructured":"Sivaraj D, Noishiki C, Kosaric N, Kiwanuka H, Kussie HC, Henn D, Fischer KS, Trotsyuk AA, Greco AH, Kuehlmann BA et al (2023) Nitric oxide-releasing gel accelerates healing in a diabetic murine splinted excisional wound model. Front Med 10:1060758. https:\/\/doi.org\/10.3389\/fmed.2023.1060758","journal-title":"Front Med"},{"key":"10600_CR28","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/bs.ircmb.2021.02.012","volume":"359","author":"F Brozzi","year":"2021","unstructured":"Brozzi F (2021) Role of MicroRNA in pancreatic beta cell function. Int Rev Cell Mol Biology 359:257\u2013286. https:\/\/doi.org\/10.1016\/bs.ircmb.2021.02.012","journal-title":"Int Rev Cell Mol Biology"},{"key":"10600_CR29","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/j.jgr.2022.12.005","volume":"47","author":"R Zhang","year":"2023","unstructured":"Zhang R, Li X, Gao Y, Tao Q, Lang Z, Zhan Y, Li C, Zheng J (2023) Ginsenoside Rg1 epigenetically modulates Smad7 expression in liver fibrosis via MicroRNA-152. J Ginseng Res 47:534\u2013542. https:\/\/doi.org\/10.1016\/j.jgr.2022.12.005","journal-title":"J Ginseng Res"},{"key":"10600_CR30","doi-asserted-by":"publisher","unstructured":"Chen Y, Wang S, Yang S, Li R, Yang Y, Chen Y, Zhang W (2021) Inhibitory role of ginsenoside Rb2 in endothelial senescence and inflammation mediated by microRNA\u2013216a. Mol Med Rep 23. https:\/\/doi.org\/10.3892\/mmr.2021.12054","DOI":"10.3892\/mmr.2021.12054"},{"key":"10600_CR31","doi-asserted-by":"publisher","first-page":"2144","DOI":"10.1002\/jcp.30001","volume":"236","author":"D Wang","year":"2021","unstructured":"Wang D, Zhao S, Pan J, Wang Z, Li Y, Xu X, Yang J, Zhang X, Wang Y, Liu M (2021) Ginsenoside Rb1 attenuates microglia activation to improve spinal cord injury via microRNA-130b-5p\/TLR4\/NF-\u03baB axis. J Cell Physiol 236:2144\u20132155. https:\/\/doi.org\/10.1002\/jcp.30001","journal-title":"J Cell Physiol"},{"key":"10600_CR32","first-page":"1505","volume":"13","author":"S Yuan","year":"2021","unstructured":"Yuan S, He G, Li L (2021) Hsa-miR-155 regulates the cell cycle and barrier function of corneal endothelial cells through E2F2. Am J Translational Res 13:1505\u20131515","journal-title":"Am J Translational Res"},{"key":"10600_CR33","doi-asserted-by":"publisher","first-page":"117147","DOI":"10.1016\/j.biopha.2024.117147","volume":"178","author":"M Sun","year":"2024","unstructured":"Sun M, Ji Y, Zhang G, Li Y, Dong F, Wu T (2024) Posttranslational modifications of E2F family members in the physiological state and in cancer: roles, mechanisms and therapeutic targets. Biomed pharmacotherapy = Biomedecine Pharmacotherapie 178:117147. https:\/\/doi.org\/10.1016\/j.biopha.2024.117147","journal-title":"Biomed pharmacotherapy = Biomedecine Pharmacotherapie"},{"key":"10600_CR34","doi-asserted-by":"publisher","unstructured":"Liu H, Chen L, Xiao W, Liu J, Long C, Zhan W, Cui C, Yang L, Chen S (2022) Alteration of E2F2 Expression in Governing Endothelial Cell Senescence. Genes 13. https:\/\/doi.org\/10.3390\/genes13091522","DOI":"10.3390\/genes13091522"},{"key":"10600_CR35","doi-asserted-by":"publisher","first-page":"27","DOI":"10.5114\/ceji.2021.105243","volume":"46","author":"W Xu","year":"2021","unstructured":"Xu W, Li S, Chang X (2021) E2F2 stimulates CCR4 expression and activates synovial fibroblast-like cells in rheumatoid arthritis. Central-European J Immunol 46:27\u201337. https:\/\/doi.org\/10.5114\/ceji.2021.105243","journal-title":"Central-European J Immunol"},{"key":"10600_CR36","doi-asserted-by":"crossref","unstructured":"Gong M, Mao Z-F, Chen J, Ye X, Zhou XJJoB, Engineering T (2020) microRNA-218 inhibits Lipopolysaccharide-Induced bronchial epithelial cell injury by targeting. E2F2:1161\u2013116910","DOI":"10.1166\/jbt.2020.2377"},{"key":"10600_CR37","doi-asserted-by":"publisher","unstructured":"Wang X, Han W, Zhang Y, Zong Y, Tan N, Zhang Y, Li L, Liu C, Liu L (2022) Soluble epoxide hydrolase inhibitor t-AUCB ameliorates vascular endothelial dysfunction by influencing the NF-\u03baB\/miR-155-5p\/eNOS\/NO\/I\u03baB cycle in hypertensive rats. Antioxid (Basel Switzerland) 11. https:\/\/doi.org\/10.3390\/antiox11071372","DOI":"10.3390\/antiox11071372"}],"updated-by":[{"DOI":"10.1007\/s11033-025-10832-5","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T00:00:00Z","timestamp":1757980800000}}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-025-10600-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-025-10600-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-025-10600-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,27]],"date-time":"2025-12-27T16:26:35Z","timestamp":1766852795000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-025-10600-5"}},"subtitle":["Rg1 improves DFU wound healing via inhibiting miR-155-5p"],"short-title":[],"issued":{"date-parts":[[2025,5,30]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["10600"],"URL":"https:\/\/doi.org\/10.1007\/s11033-025-10600-5","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,30]]},"assertion":[{"value":"27 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2025","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original online version of this article was revised: The figure 1 has been corrected.","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2025","order":8,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":9,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":10,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s11033-025-10832-5","URL":"https:\/\/doi.org\/10.1007\/s11033-025-10832-5","order":11,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiment designs and protocols were approved by the Ethics Committee of The Affiliated Nanhua Hospital, Hengyang Medical School, University of South China (Approval Number: 2024-10Y-023). The animal procedures were performed in accordance with the ARRIVE guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"523"}}